Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-&gamma;

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

405

HTML

3460

Figures (1-6)

326

Tables (1-2)

203

Sum=4394

Oct 21, 2008 (publication date) through Nov 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Oct 21, 2008; 14(39): 5980-5989
Published online Oct 21, 2008. doi: 10.3748/wjg.14.5980

Table 2 Histological localization and involved cell type in hfgl2 positive samples

Tumor type	Case	Hfgl2 positive	Histological localization and cases
Tumor type	Case	Hfgl2 positive	Tumor cell	CD57⁺	CD3⁺, CD8⁺	CD68⁺	VWF
Colon carcinoma	21	21	19	20	18	21	17
Breast cancer	20	20	18	20	20	20	18
Lung cancer	22	20	18	20	19	20	18
Gastric cancer	26	26	25	26	13	26	25
Esophageal carcinoma	19	18	18	16	15	18	14
Cervix cancer	25	22	20	21	21	22	22

Citation: Su K, Chen F, Yan WM, Zeng QL, Xu L, Xi D, Pi B, Luo XP, Ning Q. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-γ. World J Gastroenterol 2008; 14(39): 5980-5989
URL: https://www.wjgnet.com/1007-9327/full/v14/i39/5980.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5980